The intracellular life of chlamydiae

Area of Science:

• Microbiology
• Infectious Diseases
• Pathogenesis

Background:

• Chlamydial species are known for causing persistent infections in hosts.
• Persistent infections with Chlamydia trachomatis and Chlamydia pneumoniae are linked to chronic diseases like pelvic inflammatory disease, arthritis, asthma, and atherosclerosis.
• Chlamydiae possess a unique developmental cycle involving infectious elementary bodies (EB) and reproductive reticulate bodies (RB).

Purpose of the Study:

• To investigate the characteristics of persistent Chlamydia infections.
• To understand the mechanisms behind Chlamydia's ability to evade host defenses and establish chronic infections.
• To explore the implications of persistent Chlamydia infection on disease pathogenesis and treatment efficacy.

Main Methods:

• Analysis of chlamydial developmental cycle and intracellular niche.
• Induction of persistent states using cytokines (e.g., interferon-gamma), antibiotics, or nutrient restriction.
• Ultrastructural analysis of persistent Chlamydia pneumoniae.
• Gene expression profiling of persistent Chlamydia pneumoniae.

Main Results:

• Chlamydiae inhabit a non-acidic vacuole, avoiding the host endocytic pathway.
• Persistent Chlamydia exhibit reduced metabolic activity and are often antibiotic-refractory.
• IFN-gamma-treated C. pneumoniae show atypical inclusions with large, aberrant reticulate bodies (RB) and no EB redifferentiation.
• Persistent C. pneumoniae upregulate DNA replication genes but not cell division genes, explaining aberrant RB morphology.

Conclusions:

• Persistent Chlamydia infections play a significant role in the pathogenesis of various chronic diseases.
• The unique intracellular lifestyle and altered gene expression during persistence contribute to treatment challenges.
• Difficulties in diagnosing chronic Chlamydia infections impede the assessment of antibiotic therapy effectiveness.